Merck-AstraZeneca breast cancer drug Lynparza improves long-term survival, clinical trial shows
Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in ...
Tag: Merck
Merck snags Chinese obesity drug in nearly $2 billion deal
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. ...
What to know about pneumonia symptoms, spread, vaccine
Respiratory virus season has arrived, and hopefully you’re up to date on vaccinations that can help prevent infectious diseases including ...
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!